4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-26-006833
Chief Medical Officer sold 1,989 shares at $1.75 ($3,481)
- Chief Medical Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones Mitchell Lawrence Chief Medical Officer | 2026-02-11 | Option exercise | +8,000 | 15,252 | D | ||
| Jones Mitchell Lawrence Chief Medical Officer | 2026-02-12 | Sale | −1,989 | $1.75 | $3,481 | 13,263 | D |
| Derivatives | |||||||
| Jones Mitchell Lawrence Chief Medical Officer | 2026-02-11 | Option exercise · Restricted Stock Units | −8,000 | 16,000 | D | ||
| Open-market sales · 1,989 sh · avg $1.75 · $3,481 | |||||||
Loading xslF345X05/ownership.xml…